Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Acetylated Lysine Antikörper

Der Maus Monoklonal anti-Acetylated Lysine Antikörper wird verwendet zum Nachweis von Acetylated Lysine. Er wurde validiert für WB, ELISA und IHC.
Rockland
Produktnummer ABIN6655030
Hersteller Produkt- Nr.: 200-301-a97
628,53 €
Zzgl. Versandkosten 20,00 €, Trockeneispauschale 20,00 € sowie MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 5 bis 8 Werktagen

Kurzübersicht für Acetylated Lysine Antikörper (ABIN6655030)

Target

Acetylated Lysine

Reaktivität

Bitte anfragen

Wirt

  • 28
  • 19
Maus

Klonalität

  • 26
  • 20
Monoklonal

Konjugat

  • 19
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser Acetylated Lysine Antikörper ist unkonjugiert

Applikation

  • 44
  • 34
  • 33
  • 18
  • 15
  • 14
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Klon

7F8
  • Hersteller Produkt- Nr.

    200-301-a97

    Hersteller

    Rockland

    Verwendungszweck

    Lysine Acetylated Antibody

    Kreuzreaktivität (Details)

    This antibody is known to react with acetylated lysine residues from mammalian and avian sources.

    Aufreinigung

    This Protein G purified monoclonal antibody reacts with proteins containing acetylated lysine residues and does not detect non-acetylated lysine residues.

    Sterilität

    Sterile filtered

    Immunogen

    This Protein G purified monoclonal antibody was prepared using conventional hybridoma technology after repeated immunizations with acetylated keyhole limpet hemocyanin (KLH).

    Isotyp

    IgG1
  • Applikationshinweise

    ELISA_Dilution: User Optimized

    Immunohistochemistry_Dilution: 1:200 - 1:1,000

    Western_Blot_Dilution: 1:500 - 1:2,000

    Other: User Optimized

    Kommentare

    This Protein G purified antibody has been tested for use in ELISA, immunohistochemistry and western blotting.  Specific conditions for reactivity should be optimized by the end user.  Approximately 1 μg of antibody is sufficient to detect 20 μg of acetylated chicken erythrocyte histones (sodium butyrate treated) by Western blotting using HRP Gt-a-Mouse IgG (p/n 610-103-121) and chemiluminescent substrate (p/n PICOMAX-110). Antibody provided in PBS pH 7.4.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Buffer: See application note.

    Stabilizer: 50 % (v/v) Glycerol

    Preservative: 0.09 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Haltbarkeit

    12 months
  • Target

    Acetylated Lysine

    Andere Bezeichnung

    Lysine Acetylated

    Substanzklasse

    Chemical

    Hintergrund

    Synonyms: acetyl Lysine antibody, Acetylated lysine antibody, Lysine antibody

    Background: Post-translational modifications of proteins play critical roles in the regulation and function of many known biological processes. A common posttranscriptional modification of lysine residues involves acetylation (1). The conserved amino-terminal domains of the four core histones (H2A, H2B, H3 and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs) (2). Protein posttranslational reversible lysine Nε-acetylation and deacetylation have been recognized as an emerging intracellular signaling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (3). The regulation of protein acetylation status is impaired in the pathologies of cancer and polyglutamine diseases (4). HDACs therefore are promising targets for anticancer drugs currently in development (5).

Sie sind hier:
Chat with us!